Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Balow

Showing results (51-60 of 160) with videos related to

Pageof 16
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1975
Immunosuppressive effects of glucocorticosteroids: differential effects of acute vs chronic administration on cell-mediated immunityJ E Balow, D L Hurley, A S Fauci
The Journal of Clinical Investigation|July 1, 1975
Cyclophosphamide suppression of established cell-mediated immunity. Quantitative vs. qualitative changes in lymphocyte populationsJ E Balow, D L Hurley, A S Fauci
International Archives of Allergy and Applied Immunology|January 1, 1976
Cytotoxic effector capacity of bone marrow mononuclear cellsA S Fauci, J E Balow, K R Pratt
The Journal of Rheumatology|November 1, 1994
Treatment and prognosis of lupus nephritisJ E Balow, H A Austin, D T Boumpas
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1994
Structure of the VH and VL segments of monoreactive and polyreactive IgA autoantibodies to DNA in patients with systemic lupus erythematosusM T Kasaian, H Ikematsu, J E Balow, et al.
Clinical and Experimental Rheumatology|July 1, 1988
Activated T lymphocytes in the peripheral blood of patients with systemic lupus erythematosus induce B cells to produce immunoglobulinG Inghirami, J Simon, J E Balow, et al.
Arthritis and Rheumatism|July 1, 1979
Mortality in lupus nephritisJ Karsh, J H Klippel, J E Balow, et al.
Journal of Immunopharmacology|January 1, 1985
Enhancement of human allogeneic cytotoxic responses by interferonsG Inghirami, J Y Djeu, J E Balow, et al.
Annals of Internal Medicine|May 1, 1990
Intermittent cyclophosphamide for the treatment of autoimmune thrombocytopenia in systemic lupus erythematosusD T Boumpas, S Barez, J H Klippel, et al.
Clinical and Experimental Immunology|August 1, 1986
Decreased interleukin 2 inhibitor in sera of patients with autoimmune disordersJ Y Djeu, T Kasahara, J E Balow, et al.
Pageof 16

Showing results (51-60 of 160) with videos related to

Sort By:
Pageof 16
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1975
Immunosuppressive effects of glucocorticosteroids: differential effects of acute vs chronic administration on cell-mediated immunityJ E Balow, D L Hurley, A S Fauci
The Journal of Clinical Investigation|July 1, 1975
Cyclophosphamide suppression of established cell-mediated immunity. Quantitative vs. qualitative changes in lymphocyte populationsJ E Balow, D L Hurley, A S Fauci
International Archives of Allergy and Applied Immunology|January 1, 1976
Cytotoxic effector capacity of bone marrow mononuclear cellsA S Fauci, J E Balow, K R Pratt
The Journal of Rheumatology|November 1, 1994
Treatment and prognosis of lupus nephritisJ E Balow, H A Austin, D T Boumpas
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1994
Structure of the VH and VL segments of monoreactive and polyreactive IgA autoantibodies to DNA in patients with systemic lupus erythematosusM T Kasaian, H Ikematsu, J E Balow, et al.
Clinical and Experimental Rheumatology|July 1, 1988
Activated T lymphocytes in the peripheral blood of patients with systemic lupus erythematosus induce B cells to produce immunoglobulinG Inghirami, J Simon, J E Balow, et al.
Arthritis and Rheumatism|July 1, 1979
Mortality in lupus nephritisJ Karsh, J H Klippel, J E Balow, et al.
Journal of Immunopharmacology|January 1, 1985
Enhancement of human allogeneic cytotoxic responses by interferonsG Inghirami, J Y Djeu, J E Balow, et al.
Annals of Internal Medicine|May 1, 1990
Intermittent cyclophosphamide for the treatment of autoimmune thrombocytopenia in systemic lupus erythematosusD T Boumpas, S Barez, J H Klippel, et al.
Clinical and Experimental Immunology|August 1, 1986
Decreased interleukin 2 inhibitor in sera of patients with autoimmune disordersJ Y Djeu, T Kasahara, J E Balow, et al.
Pageof 16